A cell-free peptide assay reports a defined chemical or membrane-mimic result without asking the peptide to enter a living cell, remain intact, or drive a cellular endpoint. Cell-based formats add access, intracellular fate, and the chosen biological readout. A cell-free hit therefore does not automatically transfer: the cellular model may be answering a different question, or the intact peptide may never be present where the cell assay assumes it is.
This comparison uses four abstracts with first-publication dates from 9 June to 10 September 2026, retrieved on 4 October 2026. It is not a complete review of peptide assay design, and none of the abstracts reports a matched isolated-protein binding constant versus a cellular EC50 for the same intracellular target.
Access, metabolism, and the readout are separate filters
Cell-free chemical assays can rank peptides on radical scavenging without a membrane. Nuñez and colleagues hydrolyzed Salmo salar collagen sequences in silico, prioritized candidates with physicochemical descriptors, then synthesized peptides and tested them at 0.2 and 0.4 mM in DPPH and ABTS assays, a cellular antioxidant activity assay, and a WST-1 cytotoxicity assay, using vitamin C as a positive control (Nuñez et al., 18 August 2026). AS-5390 (DGCERCF) showed superior radical scavenging, with activity comparable to vitamin C in DPPH at 0.2 mM, and maintained ABTS activity at both concentrations. AS-5394 (PGDIG) produced the strongest cellular antioxidant response, approximately 40% activity at 0.4 mM. Both maintained high cell viability. Chemical rank and cellular rank therefore diverged for these two sequences.
For intracellular programs, access is measured rather than assumed. Sharar and colleagues quantified cumulative intact peptide from a cytosol-enriched soluble fraction by ESI-MS, including azide-modified cell-penetrating peptides and designed macrocycles, an impermeable negative control, multiple cell lines, and a time course (Sharar et al., 9 June 2026). Lysate total ion count was used to normalize for cell count and lysis efficiency. Mass-spectrometry permeability rankings correlated with published cellular EC50 values for the azide-modified peptides and with reported PAMPA Papp values for the macrocycles. The assay discriminated permeable from impermeable peptides across two cell lines, quantified intact internalized peptide without routine isotopic internal standards, and required about two days from seeding to data.
Liu and colleagues frame cyclization as a route to improved membrane permeability and proteolytic stability while maintaining high target affinity and specificity (Liu et al., 17 June 2026). Their bioorthogonal cell penetration assay (BCPA) uses a tetrazine-peptide and TCO-caged Nile Blue in a click-to-release reaction that liberates fluorescent Nile Blue, allowing quantitative internalization measurements in living cells. Analogue 2o bound fibroblast activation protein in vitro and in vivo; that binding claim is not the same as the internalization assay.
Even a cell-based agonist panel is not one interchangeable number. Graf and colleagues compared GLP-1 agonist bioassays reading β-arrestin recruitment, cAMP elevation, and Ca2+ mobilization, with in vivo oral glucose tolerance tests in mice (Graf et al., 10 September 2026). All systems were functional independent of the cellular mechanism; real-time Ca2+ flux confirmed endpoint data; mouse OGTT supported the representativeness of the cAMP formats. Initial validation still found inter-assay variations, after which the cAMP HTRF assay was selected for quality control and implemented in routine release testing of a commercially available GLP-1 agonist.
Why a cell-free hit often fails to transfer
Access. DPPH and ABTS do not require bilayer crossing. Cytosol-enriched intact-peptide MS and living-cell BCPA exist because internalization is not guaranteed. The impermeable negative control in the MS work is a specificity check: cell-associated signal is not automatically cytosolic intact peptide. PAMPA Papp, used as an external rank for macrocycles, is an artificial-membrane permeability number, not intact cytosolic peptide in a stated cell line.
Metabolism. The MS assay was designed to quantify intact intracellular peptide and to assess intracellular stability. The tetrazine-cyclization paper lists proteolytic stability among the reasons to cyclize. A cell-free radical assay does not report how much intact sequence survives inside cells.
Endpoint, not only occupancy. In the collagen-peptide study, chemical radical scavenging and cellular antioxidant activity ranked different sequences. In the GLP-1 study, multiple cell-based mechanisms all detected activity, yet variation among them was large enough to drive QC method selection. Transfer can fail because the peptide never arrives intact, or because the cellular assay is not measuring the same event as the cell-free assay.
These abstracts do not show that cell-free chemistry is an error. They show it is the wrong model when the question is cellular access, intactness, or a named signaling event.
Decision table: match the model to the question
| If the question is | Closer format in these sources | A hit does not establish |
|---|---|---|
| Chemical radical scavenging | DPPH or ABTS (cell-free) | Cellular antioxidant phenotype or cytosolic exposure |
| Cellular antioxidant response and viability | Cellular antioxidant assay plus WST-1 | First-rank performance in DPPH/ABTS |
| Intact cytosolic peptide, permeability rank, intracellular stability | Cytosol-enriched label-free MS; living-cell BCPA | Occupancy of a named intracellular target |
| Artificial-membrane permeability (external rank) | Reported PAMPA Papp used as a correlation for macrocycles | Intact cytosolic peptide in a stated cell line |
| A specific receptor signaling event | β-arrestin, cAMP, or Ca2+ cell-based bioassay | Equivalence to other signaling endpoints |
| Whether a cAMP GLP-1 format tracks an in vivo glucose challenge | Mouse OGTT as a cross-check of cAMP formats | That every cell-based GLP-1 assay is interchangeable for QC |
Illustrative rule from these sources: choose the format that encodes the constraint you care about. Chemical reactivity maps to a cell-free radical assay. Intact cytosolic accumulation maps to measuring intact intracellular peptide. Receptor signaling maps to naming the event (cAMP versus β-arrestin versus Ca2+) rather than treating cell-based methods as a single assay.
One specific remaining question, as of 4 October 2026, is whether cytosol-enriched intact-peptide concentration predicts functional engagement of a defined intracellular target in the same cells. The MS and BCPA abstracts quantify internalization and intactness, not target occupancy; the GLP-1 work quantifies signaling without reporting intracellular peptide mass.
Evidence limits: retrieved abstracts only, not full papers. Models are in silico collagen peptides, synthetic peptides in chemical and cell assays, two cell lines in the MS permeability work, living cells in BCPA, and mice only for OGTT confirmation of cAMP GLP-1 formats. Sample sizes and full statistics are not stated in the abstracts. The antioxidant ranking contrast is reported for two named peptides at 0.2–0.4 mM and should not be generalized across peptide classes.
Explore Further
Browse our research peptide catalog and review third-party lab reports & COAs for published batches.
---
Research use only. The information above is provided for educational and laboratory research purposes only. The compounds discussed are not approved for human or veterinary use, diagnosis, treatment, or the prevention of any disease. Nothing here is medical advice.